Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12076
Dogness International Corp
DOGZ
$15.7M
| $88.1K | ﹤0.01% |
61,619
+30,188
| +96% | +$116K |
2025 Q4
1 quarter
|
|
12077
PUT
Quantum-Si Incorporated
QSI
$339M
| $88.1K | ﹤0.01% |
113,800
-442,200
| -80% | -$458K |
2021 Q1
20 quarters
|
|
12078
Chegg
CHGG
$81.9M
| $88K | ﹤0.01% |
118,727
-270,336
| -69% | -$190K |
2017 Q1
36 quarters
|
|
12079
Invesco Advantage Municipal Income Trust II
VKI
$341M
| $88K | ﹤0.01% |
+10,157
| New | +$92.5K |
2026 Q1
0 quarters
|
|
12080
CALL
KRONOS Worldwide
KRO
$895M
| $87.4K | ﹤0.01% |
13,300
-16,900
| -56% | -$95.9K |
2025 Q3
2 quarters
|
|
12081
CALL
Runway Growth Finance
RWAY
$275M
| $87.2K | ﹤0.01% |
12,700
-500
| -4% | -$4.15K |
2025 Q4
1 quarter
|
|
|
WIW
12082
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$489M
| $87.2K | ﹤0.01% |
10,303
-7,516
| -42% | -$64.6K |
2025 Q4
1 quarter
|
|
|
PURR
12083
PUT
Hyperliquid Strategies Inc
PURR
$2.35B
| $87K | ﹤0.01% |
+17,100
| New | +$77.4K |
2026 Q1
0 quarters
|
|
12084
B&G Foods
BGS
$219M
| $86.8K | ﹤0.01% |
18,037
-153,469
| -89% | -$743K |
2021 Q3
18 quarters
|
|
|
LND
12085
BrasilAgro
LND
$350M
| $86.7K | ﹤0.01% |
20,488
-6,110
| -23% | -$24.4K |
2023 Q3
10 quarters
|
|
|
DHC
12086
PUT
Diversified Healthcare Trust
DHC
$1.87B
| $86.3K | ﹤0.01% |
13,000
-55,500
| -81% | -$352K |
2022 Q4
13 quarters
|
|
12087
PUT
Acacia Research
ACTG
$424M
| $85.6K | ﹤0.01% |
17,800
+6,300
| +55% | +$26.5K |
2025 Q4
1 quarter
|
|
|
PROF
12088
CALL
Profound Medical
PROF
$213M
| $85.5K | ﹤0.01% |
+13,200
| New | +$91.2K |
2026 Q1
0 quarters
|
|
12089
CALL
Thryv Holdings
THRY
$67.5M
| $85.5K | ﹤0.01% |
31,200
+15,200
| +95% | +$59.7K |
2025 Q4
1 quarter
|
|
|
ABTC
12090
PUT
American Bitcoin Corp
ABTC
$620M
| $85.4K | ﹤0.01% |
6,160
-13,013
| -68% | -$250K |
2025 Q3
2 quarters
|
|
12091
Crown Crafts
CRWS
$26.7M
| $85.2K | ﹤0.01% |
33,078
-30,478
| -48% | -$87.6K |
2025 Q4
1 quarter
|
|
12092
CALL
Titan International
TWI
$451M
| $85K | ﹤0.01% |
12,300
+1,500
| +14% | +$13.5K |
2021 Q4
17 quarters
|
|
12093
PUT
Fathom Holdings
FTHM
$11.4M
| $85K | ﹤0.01% |
+160,300
| New | +$160K |
2026 Q1
0 quarters
|
|
|
12094
PUT
Chegg
CHGG
$81.9M
| $84.8K | ﹤0.01% |
114,400
-59,300
| -34% | -$41.7K |
2018 Q1
32 quarters
|
|
|
LUXE
12095
PUT
LuxExperience B.V.
LUXE
$1.36B
| $84.8K | ﹤0.01% |
+10,600
| New | +$91K |
2026 Q1
0 quarters
|
|
12096
PUT
PepGen
PEPG
$158M
| $84.6K | ﹤0.01% |
+47,800
| New | +$269K |
2026 Q1
0 quarters
|
|
12097
PUT
Zura Bio
ZURA
$394M
| $84.5K | ﹤0.01% |
14,200
-49,800
| -78% | -$301K |
2025 Q3
2 quarters
|
|
|
EAD
12098
Allspring Income Opportunities Fund
EAD
$356M
| $84.4K | ﹤0.01% |
+13,029
| New | +$87.9K |
2026 Q1
0 quarters
|
|
|
ATYR
12099
CALL
aTyr Pharma
ATYR
$28.2M
| $84.4K | ﹤0.01% |
108,200
-19,000
| -15% | -$16K |
2021 Q2
19 quarters
|
|
|
12100
CALL
Acacia Research
ACTG
$424M
| $84.2K | ﹤0.01% |
17,500
+5,900
| +51% | +$24.9K |
2025 Q4
1 quarter
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.